MR编号 | AT/H/0920/001 |
---|
药品名称 | Abacavir/Lamivudin Mylan Pharma 600mg/300mg Filmtabletten |
---|
活性成分 | - Abacavir sulfate 600.0 mg
- Lamivudine 300.0 mg
|
---|
剂型 | Film-coated tablet |
---|
上市许可持有人 | Viatris Limited, Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Irland
RMS change from UK/H/6260/001 |
---|
参考成员国 - 产品名称 | Austria (AT) |
---|
互认成员国 - 产品名称 | - United Kingdom (Northern Ireland) (XI)
- Germany (DE)
Abacavir/Lamivudin Vale 600 mg/300 mg Filmtabletten - Denmark (DK)
Abacavir Lamivudin Vale - Belgium (BE)
Abacavir/Lamivudine Mylan Pharma 600 mg/300 mg filmomhulde tabletten - Netherlands (NL)
- Luxembourg (LU)
- Ireland (IE)
- France (FR)
- Spain (ES)
- Portugal (PT)
- Greece (GR)
ABACAVIR+LAMIVUDINE/VALE - Sweden (SE)
- Norway (NO)
Abakavir/Lamivudin/Vale - Finland (FI)
- Latvia (LV)
Abacavir/Lamivudine Mylan Pharma 600 mg/300 mg apvalkotās tabletes - Lithuania (LT)
Abakaviras/Lamivudinas Vale 600 mg/300 mg plėvele dengtos tabletės - Estonia (EE)
ABACAVIR/LAMIVUDINE MYLAN PHARMA - Bulgaria (BG)
Abacavir Lamivudine Vale - Romania (RO)
Abacavir/Lamivudină Viatris 600 mg/300 mg comprimate filmate
|
---|
许可日期 | 2017/09/02 |
---|
最近更新日期 | 2025/01/08 |
---|
药物ATC编码 | - J05AR02 lamivudine and abacavir
|
---|
申请类型 | - TypeLevel1:[not specified]
- TypeLevel2:[not specified]
- TypeLevel3:[not specified]
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|